公理化局部有限空间中映射连续性的扩展

用公理化方法研究了局部有限空间中的连续映射及其扩张问题。给出了局部有限空间的公理化定义方法;利用邻近关系研究了局部有限空间中的连续映射、同胚和局部同胚等问题;通过对局部有限空间变形的研究,定义了局部有限空间的一种特殊收缩核,有效地解决了局部有限空间中连续映射的扩张问题。     

大鼠血管内皮细胞siRNA转染条件的优化

目的:旨在优化siRNA转染大鼠血管内皮细胞的转染条件.方法:将0.75μL和1.5μL的脂质体LipofectamineTM3000分别与20、40、60、80nmol带荧光标记的FAMsiRNA组合,转染6、12、18、24h后,用荧光显微镜计数阳性细胞率、MTT法检测各浓度条件下内皮细胞的存活率,筛选最优转染条件.结果:(1)转染12h后,用荧光显微镜检测20、40、60、80nmol各组,均可观察到绿色荧光(2)siRNA浓度为60nmol/L,脂质体为1.5μL的组合转染效率最高,继续增加siRNA的浓度,转染效率提高不明显.(3)转染时间超过24h,各组细胞荧光减弱,细胞死亡率显著增加.结论:结果表明,以1.5μL LipofectamineTM3000与60nmol/L的siRNA浓度组成转染混合物转染12h可以实现对大鼠血管内皮细胞高效转染并保持较高的细胞活性.     

哺乳动物核移植研究进展

核移植技术具有重大的生物学的意义，特别是体细胞核移植技术的成功表明动物分化的体细胞核可再程序化，哺乳动物核移植的研究虽然还存在许多问题需要解决，但在挽救濒危动物，转基因动物研究，人类器官移植等许多方面展现了广阔的应用前景．     

Banach空间的K一致光滑性

对Banach空间给出了一种K一致光滑性的概念。证明了它与K一致凸性具有对偶性。同时还给出Banach空间成为K一致光滑空间的一个定量形式的充分条件．     

PEMFC电催化剂利用率研究方法的探讨

提高电催化剂的利用率以降低质子交换膜燃料电池(PEMFC)的成本，是加速其商业化的一个重要途径。文中讨论了现有的CV法在研究PEMFC电催化剂利用率时存在的一些问题，如CV法扫描速度的影响及Pt理论比表面积难于准确确定等，为了较好地解决这一问题，提出了一种以单位质量电催化剂产生电池功率或电能来表示膜电极中电催化剂利用率的方法。     

多波长数据线性回归光度法同时测定钙和镁

本文研究了酸性铬蓝K体系用于同时测定钙和慎的显色条件，借助多波长线性回归法处理数据，提出光度测定钙和镁的简便方法，免去了分离手续。应用于三个水样中钙、镁含量的测定，结果满意。     

光电转换体系太阳能聚集器

In standard P-V systems, the high cost and low quantum efficiency of silicon cells has held back widespread adoption of this technology for decades. To generate electrical power from solar energy in a cost effective way, most methods require the concentration of the sunlight in order to increase the efficiency of energy conversion. Most systems use parabolic mirrors to focus sunlight to either a line （trough systems） or a small volume （dishes）. One of the reasons solar power still remains little utilised, is the high cost of the collection systems. Light focussing devices using reflection usually take the form of a curved rein＇or. In contrast, this paper describes the new design of a device consisting of an array of small angled reflecting m/trot facets located in a planar form. The three dimensional angle of each facet in the array is a function of its position in the array, and is calculated to be such that for a parallel beam striking the array, each facet will reflect the light in such a way as to form a focal point region.     

Therapeutic applications of bone marrow-derived stem cells in liver transplantation for end-stage liver diseases

Today, liver transplantation (LT) is the only established treatment for end-stage liver diseases. The de- velopment of LT, including OLT, cadaveric LT, split LT, living donor LT (LDLT), brings hopes to patients with these diseases. However, increasing donor shortage, rejection and life-long immunosuppression with its side effects are the major limitations of this therapy strategy. Bone marrow-derived stem cells (BMDSCs) are capable of differentiating into hepatocyte-like cells and contribute to liver injury repair. The microenvironment of liver injury caused by rejection, ischemia/reperfusion, loss of liver mass, recurrence of HCV and "small-for-size syndrome" after LT can attract a variety of bone marrow-derived stem cell population to the peripheral circulation and then migration to the injury liver to promote the hepatic function restoration. Additionally, BMDSCs can also take part in the functional regeneration of living donor liver after LDLT. This participation in liver regeneration may be associated to the interac- tion between SDF-1and its receptor CXCR4, involving HGF, IL-8, MMP9, and VEGF/VEGFR-2. BMDSC with its bio-characteristics could maintain the allograft tolerance from different angles and in different ways. In conclusion, BMDSCs transplantation, as a new assistant therapeutic method for LT, will ex- pand the space of LT, and provide more survival opportunities for the patients suffering liver diseases in the future.     

Targeted inhibition of Livin resensitizes renal cancer cells towards apoptosis

Cancer cells are typically characterized by apoptosis deficiency. In order to investigate a possible role for the anti-apoptotic livin gene in renal cell cancer (RCC), we analyzed its expression in tumor tissue samples and in RCC-derived cell lines. In addition, we studied the contribution of livin to the apoptotic resistance of RCC cells by RNA interference (RNAi). Livin gene expression was detected in a significant portion of RCC tumor tissue specimens (13/14, 92.9%) and tumor-derived cell lines (12/15, 80.0%). Moreover, targeted inhibition of livin by RNAi markedly sensitized RCC cells towards proapoptotic stimuli, such as UV irradiation or the chemotherapeutic drugs etoposide, 5-fluorouracil, and vinblastine. These effects were specific for livin expressing tumor cells. We conclude that livin can contribute significantly to the apoptosis resistance of RCC cells. Targeted inhibition of livin could represent a novel therapeutic strategy to increase the sensitivity of renal cancers towards pro-apoptotic agents. Received 30 November 2006; received after revision 22 February 2007; accepted 20 March 2007